Yanan Li, Hua Dong. Research progress of 18F-FDG PET/CT imaging in the diagnosis and treatment of multiple myeloma[J]. Int J Radiat Med Nucl Med, 2021, 45(2): 99-104. DOI: 10.3760/cma.j.cn121381-201912031-00017
Citation: Yanan Li, Hua Dong. Research progress of 18F-FDG PET/CT imaging in the diagnosis and treatment of multiple myeloma[J]. Int J Radiat Med Nucl Med, 2021, 45(2): 99-104. DOI: 10.3760/cma.j.cn121381-201912031-00017

Research progress of 18F-FDG PET/CT imaging in the diagnosis and treatment of multiple myeloma

  • Multiple myeloma (MM) is a malignant disease of clonal plasma cell hyperplasia, which occurs mostly in the elderly. The incidence of MM ranks second in hematological malignancies and is currently on the rise in China year by year. 18F-fluorodeoxyglucose (FDG) PET/CT imaging can provide information on the proliferation and metabolism of malignant tumors at the molecular level. Existing studies have proved that 18F-FDG PET/CT is of great significance in the diagnosis, staging, monitoring of efficacy and prognostic evaluation of MM. This paper reviews the research progress of 18F-FDG PET/CT imaging in the diagnosis and treatment of MM.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return